Evonik Industries AG (FRA:EVK) Receives €23.81 Consensus Price Target from Analysts
Shares of Evonik Industries AG (FRA:EVK) have been assigned a consensus recommendation of “Hold” from the seventeen analysts that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is €23.85 ($27.73).
EVK has been the subject of several analyst reports. UBS Group set a €18.00 ($20.93) price objective on shares of Evonik Industries and gave the company a “sell” rating in a research note on Thursday, May 7th. Kepler Capital Markets set a €19.00 ($22.09) price target on Evonik Industries and gave the stock a “neutral” rating in a research note on Monday, May 4th. Barclays set a €26.00 ($30.23) price objective on Evonik Industries and gave the company a “buy” rating in a research note on Tuesday, April 7th. Warburg Research set a €28.00 ($32.56) price target on Evonik Industries and gave the company a “buy” rating in a report on Wednesday. Finally, Deutsche Bank set a €30.00 ($34.88) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a report on Thursday.
Evonik Industries stock opened at €20.80 ($24.19) on Thursday. The company’s fifty day simple moving average is €21.20 and its 200-day simple moving average is €24.11. Evonik Industries has a 12 month low of €26.78 ($31.14) and a 12 month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Read More: What is insider trading?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.